Novo Nordisk said on Friday it plans to invest more than 42 billion crowns ($6 billion) in the coming years as it seeks to meet booming demand for its Wegovy weight-loss treatment and other drugs. Read More
Weight-loss drug maker Novo Nordisk to invest $6 billion in expanding plant
Reading Time: < 1 minute